Survodutide
Survodutide from the Nexus GLP-1 & Metabolic catalog, supplied for controlled in-vitro research workflows.
Ships from the US with tracking.
Catalog active: Catalog pricing is active. Live warehouse counts are not published.
- Lot-specific COA
- HPLC + MS fields
- Batch archived
For in-vitro research use only. Not for human consumption.
Survodutide (BI 456906) is a dual-acting peptide targeting both GLP-1 and glucagon receptors. The glucagon component is studied for its effects on hepatic lipid metabolism and energy expenditure, complementing GLP-1-mediated metabolic signaling. This makes it a tool for studying liver-targeted metabolic pathways.
Survodutide definition
Survodutide is a synthetic dual glucagon / GLP-1 receptor agonist peptide. Research models examine its dual-receptor incretin and glucagon-pathway pharmacology in comparison with related compounds in the dual-agonist research family (mazdutide). Research use only.
No sequence is listed in the current catalog record for this product.
- CAS
- 2805997-46-8
- MW
- 4231.69 g/mol
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- C192H289N47O61
- Purity
- 99.69%
- Form
- Lyophilized powder
- Class
- Dual GLP-1/Glucagon Receptor Agonist
The dossier.
Compound Overview
Survodutide (BI 456906) is a dual-acting peptide studied for activity at both GLP-1 and glucagon receptors. In controlled research settings, the glucagon-receptor component is examined alongside GLP-1-mediated metabolic signaling in models involving hepatic lipid metabolism, energy-expenditure pathways, and liver-targeted metabolic biology.
Research Background & Published Literature
The Survodutide program was developed by Boehringer Ingelheim/Zealand Pharma. Published Phase 2 data in Lancet and trial registries for the SYNCHRONIZE program discuss metabolic parameters and liver-related endpoints, including MASH (metabolic dysfunction-associated steatohepatitis), as clinical-study endpoints.
Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:
Storage, Handling & Stability Guidelines
Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.
- Keep time at ambient temperature as short as practical during handling to support compound integrity.
- Reseal vials promptly after each withdrawal to limit moisture exposure.
- Use appropriate personal protective equipment and follow institutional chemical safety protocols at all times.
- For traceability, label all aliquots with compound name, concentration, reconstitution date, and operator initials.
Quality Assurance & Lab Verification
A finalized public Certificate of Analysis is available for this catalog item. Review the public COA for the applicable lot. Lot-specific identifiers, assay values, and methods are maintained in that record and are not repeated in this product dossier.
Shipping
Orders ship within the United States via USPS; international orders are not accepted. Laboratories should follow their validated SOP together with any handling fields published for the represented product or lot; no universal prepared-solution condition is inferred here.
Compound details.
- CAS Number
- 2805997-46-8
- Molecular Weight
- 4231.69 g/mol
- Class
- Dual GLP-1 / glucagon agonist
- Receptor targets
- GLP-1R + GCGR
Research context.
Studied in preclinical research models examining dual GLP-1 / glucagon receptor pharmacology, multi-receptor incretin signaling research, and comparator research within the dual-agonist family. Research use only.
Verification standard.
Certificate information is lot-specific. A finalized public record shows only the methods, fields, and results present for that named lot. A pending certificate state exposes no assay values and must not be interpreted as analytical verification. Review Nexus lab verification.
Analytical record.
- Reported HPLC purity
- 99.69%
- Retention time
- 17.20 min
- Observed mass
- 4231.90 Da
- Batch
- APX-2026-0324-S
The normalized Certificate of Analysis publishes only the lot-specific fields represented in the public record. It is not an originating laboratory report or raw instrument file.
View certificate of analysis - batch APX-2026-0324-S- Sequence
- Not listed
- Model preview
- Unavailable
Molecular model preview is unavailable for this catalog record.
The chemistry.
Dual GLP-1/glucagon receptor agonist peptide (also known as BI 456906)
Technical specifications.
- Product Name: Survodutide 10mg
- Classification: Dual GLP-1/Glucagon Receptor Agonist
- Structural Description: Dual GLP-1/glucagon receptor agonist peptide (also known as BI 456906)
- CAS Number: 2805997-46-8
- Molecular Weight: 4231.69 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
Related research compounds
Comparable catalog records with published variants and certificate status.
- GLP-1 & MetabolicVerified batchSemaglutidePriceFrom $14.99Formats6 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 910463-68-2View product - GLP-1 & MetabolicVerified batchTirzepatidePriceFrom $28.99Formats10 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 2023788-19-2View product - GLP-1 & MetabolicVerified batchRetatrutidePriceFrom $45.99Formats8 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 2381089-83-2View product - GLP-1 & MetabolicVerified batchLiraglutidePriceFrom $113.99Formats3 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 204656-20-2View product - GLP-1 & MetabolicVerified batchMazdutidePriceFrom $94.99Formats2 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 2259884-03-0View product
Survodutide research FAQ.
What is Survodutide used for in research?
Survodutide is supplied for controlled in-vitro research workflows in the GLP-1 & Metabolic category. It is not labeled for human or veterinary use.
Does Survodutide have a finalized analytical record?
Survodutide has a finalized Nexus Lab Verified record that reports 99.69% HPLC area-percent purity for the represented batch. Other fields are shown only where present.
Which Survodutide variants are published?
Published Nexus variants include 10mg.
Does Survodutide include a COA?
Yes. The current Nexus record links Survodutide to finalized batch APX-2026-0324-S.